Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen Target Range in Preterm Infants with Intermittent Hypoxemia
NCT02743988Unknown
- Sponsor
- Ulm University
- Start
- May 2015
- Primary completion
- Apr 2017
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of oxygen in intermittent hypoxemia (IH) and apnea of prematurity (AOP), sponsored by Ulm University. Primary endpoint: Duration of arterial oxygen saturation < 80% at 16 hours. Status: unknown.
02
Drugs
oxygen
03
Conditions
intermittent hypoxemia (IH)apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT02743988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743988.